Epidemiological survey of the first case of vancomycin-resistant Staphylococcus aureus infection in Europe

Epidemiology and Infection

Volumn 143, Issue 4, 2015, Pages 745-748

  Friaes A ^a   Resina, C ^b   Manuel, V ^b   Lito, L ^b   Ramirez, M ^a   Melo Cristino, J ^a,b  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b Centro Hospitalar Lisboa Norte   (Portugal)

Author keywords

Antibiotic resistance; bacterial infections; bacterial typing; infectious disease epidemiology; methicillin resistant; S. aureus (MRSA)

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; EPIDEMIOLOGICAL DATA; EUROPE; FOLLOW UP; HEALTH CARE SURVEY; HUMAN; INCIDENCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PORTUGAL; STAPHYLOCOCCUS INFECTION; VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS; DRUG EFFECTS; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; STAPHYLOCOCCAL INFECTIONS;

FEMALE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; PORTUGAL; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN RESISTANCE;

EID: 84927961883     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268814001423     Document Type: Article

References (11)

1. Sievert DM, et al. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clinical Infectious Diseases 2008; 46: 668-674.
2. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. Wayne, PA, USA: Clinical and Laboratory Standards Institute, 2013, CLSI document M100-S23.
3. Melo-Cristino J, et al. First case of infection with vancomycin-resistant Staphylococcus aureus in Europe. Lancet 2013; 382: 205.
4. Espadinha D, et al. Extensive dissemination of methicillin- resistant Staphylococcus aureus (MRSA) between the hospital and the community in a country with a high prevalence of nosocomial MRSA. PLoS One 2013; 8: e59960.
5. Finks J, et al. Vancomycin-resistant Staphylococcus aureus, Michigan, USA, 2007. Emerging Infectious Diseases 2009; 15: 943-945.
6. Kos VN, et al. Comparative genomics of vancomycinresistant Staphylococcus aureus strains and their positions within the clade most commonly associated with methicillin-resistant S. aureus hospital-acquired infection in the United States. mBio 2012; 3: e00112-12.
7. Limbago BM, et al. Report of the 13th vancomycinresistant Staphylococcus aureus isolate from the United States. Journal of Clinical Microbiology 2014; 52: 998-1002.
8. Tavares A, et al. High prevalence of hospital-associated methicillin-resistant Staphylococcus aureus in the community in Portugal: evidence for the blurring of community-hospital boundaries. European Journal of Clinical Microbiology and Infectious Diseases 2013; 32: 1269-1283.
9. Tavares A, et al. Population structure of methicillinsusceptible Staphylococcus aureus (MSSA) in Portugal over a 19-year period (1992-2011). European Journal of Clinical Microbiology and Infectious Diseases 2014; 33: 423-432.
10. Askari E, et al. vanA-Positive vancomycin-resistant Staphylococcus aureus: systematic search and review of reported cases. Infectious Diseases in Clinical Practice 2013; 21: 91-93.
11. Rossi F, et al. Transferable vancomycin resistance in a community-associated MRSA lineage. New England Journal of Medicine 2014; 370: 1524-1531.